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Characterization of non-olfactory 
GPCRs in human sperm with a focus 
on GPR18
Caroline Flegel1, Felix Vogel1,2, Adrian Hofreuter1, Sebastian Wojcik1, Clara Schoeder3, 
Katarzyna Kieć-Kononowicz4, Norbert H. Brockmeyer5,6, Christa E. Müller3, Christian Becker7, 
Janine Altmüller7, Hanns Hatt1 & Günter Gisselmann1
G protein-coupled receptors (GPCRs) transduce external chemical cues into intracellular signals and 
are involved in a plethora of physiological processes, but knowledge regarding the function of these 
receptors in spermatozoa is limited. In the present study, we performed RNA-Seq and analyzed 
the expression of the all GPCRs except olfactory receptors in human spermatozoa. We revealed the 
expression of up to 223 different GPCR transcripts in human spermatozoa (FPKM > 0.1) and identified 
GPR18, a newly described cannabinoid receptor, together with GPR137 and GPR135, as one of the three 
most highly expressed GPCRs. To date, the expression of GPR18 was completely unknown in human 
spermatozoa. We confirmed GPR18 expression using RT-PCR and immuncytochemistry experiments 
and localized the GPR18 protein in the midpiece of human spermatozoa. Stimulation of human 
spermatozoa with the GPR18 ligand N-arachidonoylglycine induced the phosphorylation of 12 protein 
kinases, some of them are for example known to be involved in the acrosome reaction. In line with 
this, N-arachidonoylglycine affected the cytoskeleton by changing levels of F-actin and inducing the 
acrosome reaction in human spermatozoa in a concentration-dependent manner. Our results indicate 
that GPR18 might be involved in physiological processes of human spermatozoa, suggesting GPR18 to 
be a potential player in sperm physiology.
Millions of spermatozoa are released into the vagina during intercourse. However, only a small number of sperm 
reach the unfertilized oocyte. On their way to the oocyte, the navigation of mammalian spermatozoa depends 
on physical and chemical cues1. G protein-coupled receptors (GPCRs) comprise the largest family of receptors 
with seven transmembrane domains and regulate a variety of physiological processes. These receptors detect 
molecules, such as neurotransmitters, chemokines, hormones or odorants. Known sperm-associated GPCRs are 
the olfactory receptors. Their functional characterization revealed a physiological role in human spermatozoa2,3. 
Nevertheless, until today the investigations of non-olfactory GPCRs in human spermatozoa are rare, and a com-
prehensive expression analysis of GPCR transcripts from human spermatozoa is lacking.
Cannabinoid receptors belong to the rhodopsin-like family of GPCRs. Two subtypes are known designated 
CB1 and CB2. In the last decade, novel GPCRs that can interact with cannabinoids have been identified. One of 
these receptors is the G protein-coupled receptor 18 (GPR18), which consists of 331 amino acids and is conserved 
among mammals4. GPR18 was initially described at the RNA level in human spleen and testis4. Furthermore, 
GPR18 mRNA was shown to be localized in murine spleen, bone marrow, thymus, lung and cerebellar tissue5.
In 2006, N-arachidonoylglycine (NAGly) was determined to be an agonist of GPR186. The endogenous 
lipid NAGly is produced in two different synthesis pathways from the endocannabinoid arachidonoylethan-
olamine (AEA)7–9. Although NAGly has a strong structural resemblance to AEA and 2-arachidonoylglycerol 
(2-AG), NAGly is not an agonist of the classical cannabinoid receptors CB1 and CB210. In addition to NAGly, 
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the plant-derived phytocannabinoid Δ 9-tetrahydrocannabinol (THC) and the structurally related synthetic 
compounds abnormal cannabidiol (Abn-CBD), O-1602, and O-1918 were described as agonists for GPR1811,12. 
Although O-1918 was previously described as an antagonist for GPR1811, a recent investigation suggested that 
O-1918 had an activating effect on GPR1812. Recently, the first selective GPR18-antagonists could be identified13. 
Even though several studies suggested that GPR18 was activated by NAGly, some others did not observe an acti-
vation of GPR18-expressing cells13,14. Recently, it was found that GPR18 can show biased activation depending 
on the employed agonist; for example β -arrestin signaling was only observed upon activation with THC, but not 
with other agonists12.
The female and male genital tract fluids contain significant concentrations of endocannabinoids and other 
lipids, which suggests that these substances may influence important physiological processes of spermatozoa, 
such as the regulation of flagellar motion, the switch of the flagellar beating mode, the direction of movement, the 
capacitation, and the acrosome reaction of spermatozoa15,16. How these environmental cues are detected and the 
signals are translated in human sperm has been explored only rudimentarily. Interestingly, NAGly was detected 
in the female reproductive tract of rat across the hormonal (estrous) cycle17.
Various studies with GPR18-expressing cells confirmed the effect of NAGly as an agonist of GPR1811,12,18. So 
far, GPR18 has been reported to be involved in cellular processes, such as cell migration11, apoptosis19, regula-
tion of MAPK activity6,11,19,20, and immune stimulation20. The signaling pathways that are induced upon GPR18 
activation are not known in detail. Coupling to Gα i/o was postulated because NAGly-induced effects could be 
inhibited by pertussis toxin6,11. Moreover, NAGly induced the phosphorylation of protein kinases, such as p44/42 
MAPK21.
In this study, we profiled the expression of non-olfactory GPCR transcripts in human spermatozoa by 
RNA-Seq and identified GPR18 as one of the most highly expressed non-olfactory GPCR transcripts. We investi-
gated the role of GPR18 in human spermatozoa and revealed that the putative endogenous GPR18 agonist alters 
physiological processes in human spermatozoa.
Results
Expression of non-olfactory GPCR transcripts in human spermatozoa determined by RNA-
Seq. To investigate the general expression of non-olfactory GPCR transcripts in human spermatozoal RNA 
samples, we performed next generation sequencing experiments (RNA-Seq). We generated mRNA-sequencing 
data for 10 human spermatozoa samples from four individual donors (Sperm 1 to 4). For sperm donors 3 and 4, 
four different datasets of four independent semen samples each were generated. A more detailed description of 
the transcriptomes will be given elsewhere22. The transcriptome analysis revealed the expression of up to 223 out 
of the 375 different non-olfactory GPCR transcripts in human spermatozoa. A list of all detected non-olfactory 
GPCR transcripts can be found in Figure S1 (mean FPKM value of all spermatozoa samples = mFPKM > 0.1). 
We detected for 14 different non-olfactory GPCR transcripts having mFPKM values higher than 30 (GPR137, 
GPR135, GPR18, S1PR2, OPRL1, CCR6, CXCR4, ADORA3, PTH1R, FPR1, C5AR1, HCAR3, HCAR2, GPR183), 
and 5 of these transcripts showed expression values higher than 100 mFPKM (GPR137, GPR135, GPR18, S1PR2, 
CXCR4) in one or more spermatozoa samples. Out of these 223 detected non-olfactory GPCRs, we generated a 
ranking of the 20 most highly expressed non-olfactory GPCR transcripts in human spermatozoa and compared 
their expression intensities to testis and different reference tissue samples (brain, colon, liver, lung, skeletal mus-
cle) (Fig. 1A). The three highest mFPKM values were found for GPR137 (1004 mFPKM), GPR135 (208 mFPKM), 
and GPR18 (86 mFPKM).
Based on FPKM values, GPCR-transcripts were in the same expression range, such as the housekeeping genes 
GAPDH (842 mFPKM) and RPL29 (219 mFPKM) (Figure S3). GPR137 and GPR135 are orphan receptors. 
GPR137 is ubiquitously expressed5 and has a possible role in tumor cell growth23. The GPR135 gene is a target for 
hypermethylation in ovarian cancer genesis24. However, the physiological function of both receptors is unknown. 
For GPR18, activation by cannabinoids and related lipids has been described6,11,12,18. We detected a coherent and 
high expression for GPR18 transcripts in all of the spermatozoa and testis samples investigated (sperm: a mFPKM 
of 86.4 (ranging from 38 to 173, testis: a mFPKM 9.7 (ranging from 3 to 25)), whereas the expression of GPR18 
transcripts in the reference tissues was low (≤ 0.52 FPKM), indicating a selective expression in sperm and testis 
(Figs 1A and S4, S5).
For 7 out of the 20 most highly expressed GPCR transcripts, the function is associated with reproduction 
or fertilization (Fig. 1A). Most of these already described functions for GPCRs are related to the motility of 
sperm25–29.
Furthermore, we performed RT-PCR experiments to confirm the RNA-Seq data of spermatozoa for GPR18 
(Figs 1B and S4) as well as for 5 additional GPCRs. We selected GPCR genes with and without a known expres-
sion in human sperm from the 20 most highly expressed GPCRs. We confirmed all of the GPCR transcripts 
detected by RNA-Seq using RT-PCR (Fig. 1B). Furthermore, we confirmed the known transcript variants for 
GPR18 (Accession number: NM_005292 and NM_001098200) via RT-PCR, concluding that both variants are 
expressed in human spermatozoa (Fig. 1B).
GPR18 protein is localized to the midpiece of human spermatozoa. In this study, we focused 
on the functional characterization of GPR18 in human spermatozoa because this receptor is the most highly 
expressed GPCR in human spermatozoa, and the receptor has a known ligand profile. First, we investigated 
whether GPR18 can be detected at the protein level in human spermatozoa. For the detection of GPR18 proteins, 
we performed immunocytochemical staining with human spermatozoa. The antibody specificity was previously 
verified11, and the secondary antibody without primary antibody did not produce any specific staining (Figure S6). 
Apart from mRNA-expression of GPR18 in human spermatozoa via RNA-Seq and RT-PCR, GPR18 was detected 
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at the protein level in all human spermatozoa investigated (Fig. 2). Staining was restricted from the central to 
distal parts of the midpiece, whereas the head was not stained. In the flagella, we detected weak GPR18 staining.
The GPR18 ligand NAGly induced the phosphorylation of protein kinases. To investigate the 
potential physiological function of GPR18 in human spermatozoa, we examined the effect of the reported GPR18 
agonist NAGly in human spermatozoa. Different protein kinases are important regulators of cellular mechanisms. 
In sperm, the activation of protein kinases is involved in central physiological processes, such as capacitation or 
acrosomal exocytosis30. We investigated the phosphorylation status of 40 different protein kinases upon NAGly 
stimulation in human spermatozoa using a phospho-kinase array (Fig. 3A). The stimulation of cells with 3 μ M 
NAGly (7 min) induced the phosphorylation of 12 different kinases (Akt, p53, p70 S6, RSK1/2/3, STAT3, p27, 
PYK2, STAT5a, PLC-γ 1, HSP60, WNK1, STAT6). For five kinases, we detected a decreased phosphorylation 
(CREB, EGFR, AMPKα 1, MSK1/2, and HSP27) in comparison to control cells (Fig. 3B). The highest phospho-
rylation level was observed for the T308 phosphorylation site of the Akt kinase (451%) and the p70 S6 kinase at 
T421 and S424 (555%) compared with the control.
We used western blot analysis to validate the effect of NAGly on the phosphorylation site T308 of the Akt 
kinase. We confirmed that NAGly increased Akt phosphorylation after 7 min of agonist exposure. The quantifica-
tion of western blot experiments validated this significant effect (p = 0.016, Fig. 3C).
An important mediator of processes in spermatozoa, such as the control of hyperactivation, is the induction 
of changes in calcium concentration (reviewed in ref. 31). Therefore, we performed single-cell calcium imag-
ing experiments with human spermatozoa to investigate if NAGly induces a change of the intracellular calcium 
concentration in human sperm. Upon short-term application (20 s) of 10 μ M NAGly, no increase in intracellular 
calcium concentrations were observed in human spermatozoa (Fig. 3D). The usage of the control stimulus pro-
gesterone (500 nM) induced strong calcium signals.
Figure 1. Determination of GPCR transcript levels in human spermatozoa. (A) Shown are the 20 most 
highly expressed GPCR transcripts in human spermatozoa from four different donors. For sperm donors 3 and 
4, four different datasets of four independent semen samples each were generated (Sperm 1, 2, 3-1, 3-2, 3-3, 3-4, 
4-1, 4-2, 4-3, 4-4) Data were compared to ten different testis samples (Testis 1–10), brain (B), colon (C), liver 
(LI), lung (LU) and skeletal muscle (SM). GPCRs are sorted by the mean FPKM in spermatozoa. The FPKM 
values are an indicator for expression strength of transcripts and are represented by color intensity. Ligand: 
describes which ligand is known for the respective GPCR. Associated function to sperm: describes whether a 
function of the respective GPCR is known in sperm. n.a.: not available. (B) RT-PCR analysis of GPCRs obtained 
from RNA-Seq. Gel electrophoresis of the amplified PCR products from cDNA samples of human sperm and 
testis samples. For GPR18 we detected both transcript variants. The highly expressed sperm-specific transcript 
CRISP2 was used as a positive control59. Used primer pairs were intron-spanning excluding gDNA amplified 
products. M: Marker in bp.
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NAGly induced a reorganization of the cytoskeleton and enhanced the acrosomal exocytosis 
in human spermatozoa. The protein kinases Akt and p70 S6 are involved in actin cytoskeleton dynamics 
in human spermatozoa32. Furthermore, an involvement of PLCγ in the reorganization of the cytoskeleton 
was shown33,34. We investigated the effect of NAGly on cytoskeleton dynamics by detecting F-actin (Fig. 4A). 
Phalloidin detected F-actin was enriched in the acrosomal region of control cells, defining the profile of the acro-
some vesicle. In NAGly-stimulated cells, this staining was significantly reduced, especially in the acrosomal cap 
(Fig. 4B). After treatment with NAGly (3 μ M) for 3 h, the cells showed significant alterations in the cytoskeleton 
(Fig. 4C).
A decreased amount of F-actin is an indicator of the acrosome reaction in spermatozoa35–37. Therefore, we 
investigated acrosomal exocytosis in human spermatozoa upon NAGly stimulation (Fig. 4D,E). The acrosomal 
status was divided into four categories (I-IV) as described in ref. 38. Category I corresponds to a complete acro-
somal cap, category II to a nearly complete acrosomal cap, category III to a nearly complete acrosomal exocytosis 
and category IV to complete acrosomal exocytosis; Fig. 4D. After 1 h of NAGly stimulation at different concen-
trations, we detected a significant concentration-dependent increase of spermatozoa with a nearly complete or 
a complete acrosomal exocytosis (category III and IV). NAGly (10 μ M) was as potent as the positive controls 
progesterone and ionomycin.
NAGly- and THC-induced acrosomal exocytosis is mediated by GPR18 in human spermato-
zoa. To confirm that NAGly-induced effects are mediated by GPR18 activation, we used specific GPR18 antag-
onists13 (Supporting Information). The co-application of the selective GPR18 antagonist PSB-CB5 and PSB-CB27 
with NAGly (1:1, 1 μ M) completely blocked the NAGly-induced acrosomal exocytosis in human spermatozoa 
(Fig. 5). The results showed that the NAGly-induced acrosomal exocytosis is mediated by the activation of GPR18 
in spermatozoa. Furthermore, we investigated the effects of the phytocannabinoid THC (Figure S7). The can-
nabinoid also induced the acrosomal exocytosis. Again, these effects could be inhibited by the specific GPR18 
antagonists PSB-CB5 and PSB-CB27.
Discussion
GPCRs form the largest family of transmembrane signaling receptors and regulate a plethora of physiologi-
cal and pathophysiological processes. To our knowledge, this is the first comprehensive expression analysis of 
non-olfactory GPCR transcripts in motile human spermatozoa. We revealed the expression of 223 different 
non-olfactory GPCRs. For 7 out of the 20 most highly expressed GPCRs, the expression as well as the function 
was already described in sperm, indicating the significance of these RNA-Seq data sets. In addition, we described 
the expression of newly identified non-olfactory GPCR-transcripts in spermatozoal RNA. Thirteen out of the 
twenty most highly expressed GPCRs were not described in human spermatozoa so far.
We detected a high level of GPR18 expression for the first time in human spermatozoa. GPR18 is the most 
highly expressed GPCR for which ligands are known. Additionally, we demonstrated GPR18 expression at the 
protein level in the midpiece of spermatozoa using immunocytochemical staining.
Many effects of GPR18 in different types of cells were previously shown11,18,19. However, the functional role of 
GPR18 in spermatozoa has so far not been determined.
Figure 2. GPR18 protein is localized to the midpiece of human spermatozoa. Immunocytochemical 
staining of human spermatozoa with an α -GPR18 antibody (green). DAPI staining (blue) was used to 
determine the number and location of spermatozoa. Scale bars: 10 μ m. Enlarged: *indicated the zoomed 
section. Scale bar: 5 μ m.
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The agonist of GPR18, NAGly, induced the activation of several protein kinases in spermatozoa. This acti-
vation might be involved in actin bundling in human spermatozoa, as well as in the induction of the acrosome 
reaction. Stimulation with the GPR18 ligand induced a strong phosphorylation of Akt and p70 S6 kinases. 
Furthermore, PLCγ was phosphorylated upon NAGly stimulation. These protein kinases play regulatory roles in 
actin polymerization in human sperm32,34,39.
During the physiological reorganization of sperm that happens between ejaculation and fertilization, the 
structure of actin in the sperm cells changes several times. After ejaculation, G-actin monomers are predom-
inantly present in sperm. After capacitation in the female genital tract, this G-actin is polymerized to F-actin. 
This process increases the motility of the cells36,40–43. As part of the last stages of acrosomal exocytosis, which 
is triggered upon reaching the ovum, the F-actin is cleaved again to G-actin (Liu et al.35, 2002, Brener et al.36). 
This is a necessary process that enables the outer acrosomal membrane and the plasma membrane to come into 
close proximity and fuse44. NAGly stimulation led to the depolymerization of F-actin and induced the acrosomal 
exocytosis in human sperm. This indicates that the NAGly activation of GPR18 is important for the physiology of 
sperm just it penetrates the oocyte.
Preliminary data indicated no chemotactic effect upon NAGly stimulation using a capillary chemotaxis assay 
as described in ref. 45. An effective influence on the motility was not be proven. The effect of NAGly stimulation 
on the flagellar beat frequency should be investigated in future experiments.
Figure 3. The GPR18 ligand NAGly induced the phosphorylation of different protein kinases in human 
sperm. (A) Human phospho-kinase array analysis revealed phosphorylation events induced by NAGly (3 μ M)  
after 7 min stimulation. (B) Shown are the relative phosphorylation (mean pixel intensities relative to control) 
of two independently performed experiments using two different donor samples. Each array was performed 
using pooled protein lysates of at least three different semen samples from the same donor. The dotted 
line indicates the control level. (C) Western Blot experiments validated the phosphorylation of Akt at the 
T308 phosphorylation site. Determination of the total amount of Akt served as a control. Furthermore, the 
quantification of the mean pixel intensity of phosphorylated Akt relative to total Akt upon NAGly stimulation 
(black bar) is shown. The ratio was normalized to that observed in DMSO-treated cells (0.1%; control; gray bar). 
Error bar represents the mean ± SEM (p = 0.016, Student’s t-test, n = 4 experiments). (D) In single-cell calcium 
imaging experiments, the repetitive short-term stimulation with 10 μ M NAGly did not induce any calcium 
signals in human spermatozoa. Cytosolic Ca2+ levels are monitored as the integrated f340/f380 fluorescence 
ratio expressed as a function of time. Black bars indicate the stimulus duration. The positive control (500 nM 
progesterone) induced strong calcium signals in virtually all sperms and showed the vitality of the sperm and 
the functionality of the imaging system. In none of the 453 analyzed cells from 4 different sperm samples NAGly 
induced a Ca2+ signal.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:32255 | DOI: 10.1038/srep32255
Figure 4. NAGly induced the reorganization of actin filaments and the acrosome reaction in human 
spermatozoa. (A) F-actin staining using FITC-conjugated phalloidin (green) of NAGly-stimulated (3 μ M) 
spermatozoa and control cells (0.1% DMSO). The cells were incubated for 3 h. DAPI staining (blue) was used 
to determine the number and localization of cell nuclei. Scale bars: 10 μ m. (B) Zoomed section of NAGly-
stimulated (3 μ M) and control spermatozoa stained with phalloidin-FITC (Phalloidin). Scale bars: 1 μ m.  
(C) Quantification of relative fluorescence intensities revealed a significant reduction of F-actin levels upon 
NAGly stimulation in human sperm. Shown are the mean ± SEM (DMSO: n = 95 cells; NAGly: n = 95 cells; 
from three independent experiments; Mann-Whitney-U-Test: ***p < 0.001). (D) Representative pictures of the 
PNA-FITC (PNA) staining of control and NAGly-stimulated cells. Marked are the different categories of the 
acrosomal status (I-IV). DAPI staining (blue) was used to determine the number and localization of cell nuclei. 
Scale bars: 10 μ m. (E) Quantification of acrosomal exocytosis (categories III-IV) upon NAGly stimulation using 
PNA-FITC. Stimulated cells (NAGly) were compared to control cells (0.1% DMSO); Three to five independent 
samples with a sperm population ranging from 97 to 364 cells per single experimental condition were analyzed. 
Values show the mean ± SEM (*p < 0.05, ***p < 0.001, Student’s t-test).
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NAGly is an endogenous lipid that is found throughout the human body, including the female reproductive 
tract. In the uterus of rodents, varying concentrations of NAGly were detected during the hormonal cycle (estrus: 
~40 pmol/gram uterus tissue)17. The highest concentration of NAGly was cycle-dependently detected before and dur-
ing ovulation46. In addition, it was demonstrated that the expression of fatty acid amide hydrolase, which catalyzes 
the synthesis of endogenous NAGly9, also varies in the female menstrual cycle of rats47. Furthermore, the GPR18 
agonist NAGly induced migration of endometrial cells21. Thus, future studies should identify if changes in NAGly 
levels in the endocannabinoid system in human females might influence the effectiveness of a successful fertilization. 
However, appropriate studies on the presence of NAGly in the female genital tract of humans are still lacking.
The use of the specific GPR18 antagonists showed the direct GPR18 involvement in the agonist-induced 
effects (NAGly, THC) observed in this study. We can therefore exclude the involvement of cannabinoid CB1 or 
CB2 receptors in the detected NAGly- and THC-induced effects in human spermatozoa.
However, we cannot exclude that the NAGly-induced effects in human spermatozoa may be partially mediated 
by lipid receptors distinct from GPR18, CB1 or CB2. But the expression of other known or putative cannabinoid-like 
and lipid receptor transcripts is extremely low (Figure S8). Nevertheless, a second described NAGly receptor 
LPAR5 (GPR92), is also expressed in human spermatozoa (mFPKM = 1.5), but at a much lower level than GPR18. 
Additionally, LPAR5 can only be partially activated by higher concentrations of NAGly (EC50 = 4.5 μ M)48,49, 
whereas GPR18 can be activated by lower concentrations in stably transfected HEK293 cells (EC50 = 44.5 nM)21. 
In the present study, we also showed that low NAGly concentrations (10 nM) induced acrosomal exocytosis, sug-
gesting that LPAR5 is not involved in NAGly-induced effects. Known antagonists for LPAR550 could be tested in 
future experiments to completely exclude the potential involvement of LPAR5 in NAGly-induced effects in sperm.
In addition to the endogenous lipid NAGly, we and others could show that GPR18 can be activated by the 
phytocannabinoid THC12,13,21,51–53. A previous study showed that THC attenuates mouse sperm motility54. 
Further studies should investigate if the use of marijuana influences reproduction via GPR18 in males as well 
as in females. It would be conceivable that activation of GPR18 would have an effect in the male reproductive 
tract (early sperm acrosome reaction or sperm motility) as well as in the female reproductive tract (activation of 
GPR18 independently of the regular hormonal cycle).
Conclusions
RNA-Seq analysis of human spermatozoa revealed the expression of 223 different non-olfactory GPCR tran-
scripts. One of the most highly expressed GPCRs was the NAGly-sensitive GPR18. Stimulation with NAGly and 
thus the activation of GPR18 is involved in key physiological processes of human spermatozoa. NAGly induced 
the reorganization of actin filaments and induced acrosomal exocytosis. Together, the GPR18 activation might 
play an important role, particularly immediately prior to fertilization. Our findings indicate the involvement of a 
new cannabinoid receptor in male reproduction.
Materials and Methods
Human semen collection preparation. Human sperm were freshly obtained from young healthy donors 
who gave informed signed consent. Samples were used anonymously. Sperm collection and analysis was per-
formed according to the local regulations and approved by the local ethics committee of the Ruhr-University 
Bochum (Reg.-Nr. 2231). For RNA isolation, Ca2+ imaging, acrosome assay, F-actin staining, western blot exper-
iments, Phospho-Kinase array, and immuncytochemistry experiments, motile spermatozoa were obtained as 
follows. After liquefaction (30 min at 35.5 °C) to isolate mature and motile sperm, a Percoll density gradient 
centrifugation was performed as described previously2. Liquefied semen was overlaid on a two-layer Percoll (cell 
Figure 5. NAGly-induced effects are mediated via GPR18 in human spermatozoa. Quantification of 
acrosomal exocytosis (categories III-IV) upon co-stimulation of 1 μ M NAGly and the selective GPR18 
antagonists PSB-CB5 (1 μ M) and PSB-CB27 (1 μ M) using PNA-FITC. Stimulated cells (NAGly + antagonist) 
were compared to control cells (0.1% DMSO); four independent samples with a sperm population ranging from 
143 to 260 cells per single experimental condition were analyzed. Values show the mean ± SEM (**p < 0.01, 
Student’s t-test).
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culture tested, Sigma-Aldrich, MO, USA) density gradient and centrifuged at room temperature for 40 min at 
300 g. The pellet was collected, washed in standard Ringer’s solution (140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 
2 mM MgCl2, 10 mM Hepes, 10 mM glucose, pH 7.4), and again centrifuged for 15 min. Then, the pellet of motile 
spermatozoa was resuspended in Ringer’s solution and used for further experiments.
RNA isolation. The isolation of spermatozoal RNA was performed using the RNeasy Plus Mini Kit (Qiagen, 
Hilden, Germany) according to the manufacturer’s protocol including DNaseI digestion.
Transcriptome analysis. Basic NGS analysis was done as previously described22. Briefly, for transcrip-
tome analysis RNA from human motile spermatozoa was prepared as stated above. At the Cologne Center for 
Genomics Next Generation Sequencing unit, libraries for next generation sequencing were constructed from 
mRNA. RNA-Seq was performed on the Illumina HiSeq2000 sequencing platform as paired-end reads with 
101-nucleotide length. Raw sequence data were aligned to the human reference genome hg19 using the TopHat 
software. BAM-files were sorted and indexed using the Samtools software package55. FPKM (fragments per 
kilobase of exon per million fragments mapped) values were calculated using the Cufflinks software. For the cur-
rent study, we extracted the values for GPCRs out of this data set. A comprehensive description of the transcrip-
tome of spermatozoa was given elsewhere22. For comparison to spermatozoa transcript expression, we reanalyzed 
already published raw data in the same manner as RNA-Seq data of spermatozoa samples. We reanalyzed data 
from 8 different testis samples obtained from the Array Express Archive (www.ebi.ac.uk/arrayexpress/; accession 
number: E-MTAB-1733). The five reference tissues as well as Testis 1 were obtained from the Body Map 2.0 pro-
ject from the NCBI GEO database (http://www.ncbi.nlm.nih.gov/gds/; accession number: GSE30611). Raw data 
of Testis 2 were obtained from56.
Reverse transcriptase (RT)-PCR. RNA from motile spermatozoa was reverse transcribed using the iScript 
cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA) according to the manufacturer’s instructions. An 
equivalent of ~30 ng of RNA was used for each RT-PCR experiment. We designed exon-exon spanning primers 
that detect ~150–450 bp of the respective gene (Figure S2). PCR was performed using GoTaq qPCR Master Mix 
(Promega, Madison, WI, USA) with the Mastercycler realplex2 (Eppendorf, Hamburg, Germany) (20 μ l total vol-
ume, 40 cycles: 95 °C, 59 °C, 72 °C, 45 s each). All experiments were conducted in triplicate.
Phospho-Kinase Array. The Proteome Profiler Human Phospho-Kinase Array (ARY003; R&D Systems, 
Inc., MN, USA) was used to detect kinase phosphorylation according to the manufacturer’s protocol. In brief, 
motile sperm were stimulated with 3 μ M NAGly or the equivalent amount of DMSO (0.1%) for 7 min. Afterwards, 
proteins were isolated and 200 μ g protein was applied to each array set. In this method, proteins are captured by 
antibodies spotted on a nitrocellulose membrane. Levels of phosphorylated protein are then assessed using an 
HRP-conjugated antibody followed by chemiluminescence detection. The amount of chemiluminescence was 
detected and analyzed with the ImageJ software using a microarray plug in ref. 57.
Western Blot Analysis. Sperm cells were treated with 3 μ M NAGly for 7 min, pelleted by centrifugation 
at 500 g for 5 min, washed with PBS, and homogenized in lysis buffer (50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 
1 mM EDTA, and 1% Triton X-100) with protease and phosphatase inhibitors (PhosSTOP Phosphatase Inhibitor 
Cocktail Tablets, Roche, Basel, Switzerland). Western Blot analyses were performed as previously described58. The 
following primary antibodies were used: Akt total, phospho-Akt T308 (Cell Signaling Technology). Antibodies 
were diluted (1:1000) in 3% blocking reagent in Tris buffered saline + 0.1% Triton-X-100. After washing, mem-
brane was incubated with HRP-coupled secondary antibody and followed up with chemiluminescence detection 
(ECL Select Western Blotting Detection System, Amersham Biosciences, GE Healthcare, Solingen, Germany). 
The data were quantified using ImageJ software57. The ratio of the average intensity of the phosphorylated sample 
band and the average intensity of unphosphorylated sample band exhibited the relative intensity.
Immunocytochemical staining. For immunocytochemical staining, motile spermatozoa plated on 
poly-l-lysine coated cover slips were fixed with 4% paraformaldehyde (20 min, room temperature). Afterwards, 
cells were permeabilized with PBS−/− + 0.1% Triton X-100 and incubated with blocking reagent (PBS−/− + 0.1% 
Triton X-100, 5% normal goat serum, and 1% fish gelatin) for 1 h. Primary antibody was incubated overnight 
(4 °C). The following antibody was used: α -GPR18, 1:100 (kindly provided from Ken Mackie, Indiana University). 
Antibody-specificity was proven in ref. 11. Alexa-conjugated secondary antibody (Alexa Fluor 488 Goat 
Anti-Rabbit, Invitrogen, Denmark) was incubated for 45 min at room temperature in the absence of light. Probes 
were mounted in ProLong Gold antifade (Invitrogen, Denmark). Images were obtained using a confocal fluores-
cent microscope (LSM 510 Meta, Zeiss).
Calcium imaging experiments. Calcium imaging experiments with human spermatozoa were performed 
as described previously in ref. 2.
Acrosome assay. For analysis of acrosome reactions sperm were incubated with the respective substance 
for 1 h at 37 °C. As control, sperm were incubated in 0.1% DMSO. Next, 100 μ l of the sperm suspension was 
transferred on a microscope slide. The samples were air-dried and fixed for 20 min in 4% paraformaldehyde at 
room temperature. For acrosome staining, samples were incubated with 5 μ g/ml peanut agglutinin (PNA)-FITC 
(Sigma-Aldrich, MO, USA) in PBS−/− for 45 min in the dark at room temperature. During this incubation, 
sperm were counterstained with DAPI (Invitrogen, Denmark). Samples were mounted in ProLong Gold antifade 
(Invitrogen, Denmark). Slides were analyzed using a confocal fluorescent microscope (LSM 510 Meta, Zeiss).
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F-actin staining. For the analysis of cytoskeletal changes, sperm were incubated with NAGly (3 μ M) for 3 h 
at 37 °C. As a control, sperm cells incubated with an equivalent of DMSO (0.1%), were used. After stimulation, 
cell suspensions were transferred to poly-l-lysine-coated cover slips in 24-well plates. After washing with Ringer’s 
solution, cells were fixed using 4% PFA for 20 min at room temperature. Cells were incubated for 5 min with PBST 
(PBS−/− + 0.1% Triton X-100), after two washes with PBS−/−. For F-actin staining, cells were incubated with 
Phalloidin-FITC (50 μ g/ml, Invitrogen, Denmark) in PBST for 20 min at room temperature in the dark. During 
this incubation, a counterstaining with DAPI was performed. After washes with PBS−/, samples were mounted in 
ProLong Gold antifade (Invitrogen, Denmark).
Test compounds. Appropriate stock concentrations of the chemicals tested were prepared in 100% DMSO. 
The desired final working concentrations were achieved by serially diluting the stock solutions with Ringer’s 
solution (each containing 0.1% DMSO).
Statistical analysis. Statistical analysis was performed using SigmaPlot 12.3. The results are presented as 
the mean ± standard error of mean (SEM) and (n) is the number of cells/experiments. The significance was set as 
*p < 0.05, **p < 0.01, ***p < 0.0001.
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